Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Illa

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Plos One|November 19, 2008
Gene expression profiling in limb-girdle muscular dystrophy 2AAmets Sáenz, Margarita Azpitarte, Rubén Armañanzas, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Identification of serum microRNAs as potential biomarkers in Pompe diseaseAna Carrasco-Rozas, Esther Fernández-Simón, Maria Cinta Lleixà, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 18, 2021
Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsiesXavier Suárez-Calvet, Esther Fernández-Simón, Patricia Piñol-Jurado, et al.
Cell Death & Disease|July 12, 2018
Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathyPatricia Piñol-Jurado, Xavier Suárez-Calvet, Esther Fernández-Simón, et al.
Annals of Neurology|January 8, 2014
Atypical phenotypes in titinopathies explained by second titin mutationsAnni Evilä, Anna Vihola, Jaakko Sarparanta, et al.
The American Journal of Pathology|May 23, 2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease PatientsAna Carrasco-Rozas, Esther Fernández-Simón, Xavier Suárez-Calvet, et al.
The Lancet. Neurology|November 19, 2020
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, et al.
Annals of Neurology|March 10, 2011
Investigations of caspr2, an autoantigen of encephalitis and neuromyotoniaEric Lancaster, Maartje G M Huijbers, Vered Bar, et al.
Annals of Clinical and Translational Neurology|June 22, 2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravisElena Cortés-Vicente, Ricard Rojas-Garcia, Jordi Díaz-Manera, et al.
Annals of Clinical and Translational Neurology|July 22, 2025
Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal FeaturesLaura Llansó, Igor Stevanovski, Germán Morís, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Plos One|November 19, 2008
Gene expression profiling in limb-girdle muscular dystrophy 2AAmets Sáenz, Margarita Azpitarte, Rubén Armañanzas, et al.
Annals of Clinical and Translational Neurology|July 30, 2019
Identification of serum microRNAs as potential biomarkers in Pompe diseaseAna Carrasco-Rozas, Esther Fernández-Simón, Maria Cinta Lleixà, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 18, 2021
Isolation of human fibroadipogenic progenitors and satellite cells from frozen muscle biopsiesXavier Suárez-Calvet, Esther Fernández-Simón, Patricia Piñol-Jurado, et al.
Cell Death & Disease|July 12, 2018
Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathyPatricia Piñol-Jurado, Xavier Suárez-Calvet, Esther Fernández-Simón, et al.
Annals of Neurology|January 8, 2014
Atypical phenotypes in titinopathies explained by second titin mutationsAnni Evilä, Anna Vihola, Jaakko Sarparanta, et al.
The American Journal of Pathology|May 23, 2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease PatientsAna Carrasco-Rozas, Esther Fernández-Simón, Xavier Suárez-Calvet, et al.
The Lancet. Neurology|November 19, 2020
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, et al.
Annals of Neurology|March 10, 2011
Investigations of caspr2, an autoantigen of encephalitis and neuromyotoniaEric Lancaster, Maartje G M Huijbers, Vered Bar, et al.
Annals of Clinical and Translational Neurology|June 22, 2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravisElena Cortés-Vicente, Ricard Rojas-Garcia, Jordi Díaz-Manera, et al.
Annals of Clinical and Translational Neurology|July 22, 2025
Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal FeaturesLaura Llansó, Igor Stevanovski, Germán Morís, et al.
Pageof 14